Roche To Take Ionis Drug Forward Into Crowded Nephropathy Field

Also Has Potential In AMD

 
• By Andrew McConaghie
  
Ionis HQ
Roche will lead the Phase III development of the therapy, based on Ionis' antisense drug platform. • Source: Ionis

More from Deals

More from Business